» Articles » PMID: 37891477

Cellular Senescence in Skeletal Disease: Mechanisms and Treatment

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The musculoskeletal system supports the movement of the entire body and provides blood production while acting as an endocrine organ. With aging, the balance of bone homeostasis is disrupted, leading to bone loss and degenerative diseases, such as osteoporosis, osteoarthritis, and intervertebral disc degeneration. Skeletal diseases have a profound impact on the motor and cognitive abilities of the elderly, thus creating a major challenge for both global health and the economy. Cellular senescence is caused by various genotoxic stressors and results in permanent cell cycle arrest, which is considered to be the underlying mechanism of aging. During aging, senescent cells (SnCs) tend to aggregate in the bone and trigger chronic inflammation by releasing senescence-associated secretory phenotypic factors. Multiple signalling pathways are involved in regulating cellular senescence in bone and bone marrow microenvironments. Targeted SnCs alleviate age-related degenerative diseases. However, the association between senescence and age-related diseases remains unclear. This review summarises the fundamental role of senescence in age-related skeletal diseases, highlights the signalling pathways that mediate senescence, and discusses potential therapeutic strategies for targeting SnCs.

Citing Articles

A 7T MRI Study of Fibular Bone Thickness and Density: Impact of Age, Sex and Body Weight, and Correlation with Bone Marrow Expansion and Muscle Fat Infiltration.

Johnson T, Su J, Henning A, Ren J Diagnostics (Basel). 2025; 15(5).

PMID: 40075811 PMC: 11899192. DOI: 10.3390/diagnostics15050564.


Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.


The Role of mRNA Modifications in Bone Diseases.

Li Z, Meng K, Lan S, Ren Z, Lai Z, Ao X Int J Biol Sci. 2025; 21(3):1065-1080.

PMID: 39897026 PMC: 11781163. DOI: 10.7150/ijbs.104460.


Mechanism of hyperbaric oxygen therapy downregulating H-type angiogenesis in subchondral bone of knee osteoarthritis through the PHD2/HIF-1α pathway.

Wang J, Yu W, Zhang Y, Chen B, Meng Z J Orthop Surg Res. 2025; 20(1):79.

PMID: 39844325 PMC: 11752633. DOI: 10.1186/s13018-025-05514-8.


The pathogenesis and targeted therapies of intervertebral disc degeneration induced by cartilage endplate inflammation.

Yang H, Chen X, Chen J, Dong Y, Huang Y, Qin L Front Cell Dev Biol. 2024; 12:1492870.

PMID: 39687521 PMC: 11647014. DOI: 10.3389/fcell.2024.1492870.


References
1.
Liu J, Zhang J, Lin X, Boyce B, Zhang H, Xing L . Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. J Clin Invest. 2022; 132(8). PMC: 9012290. DOI: 10.1172/JCI148073. View

2.
Kushchayeva Y, Pestun I, Kushchayev S, Radzikhovska N, Lewiecki E . Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing. J Clin Med. 2022; 11(24). PMC: 9781093. DOI: 10.3390/jcm11247477. View

3.
Li G, Yu M, Lee W, Tsang M, Krishnan E, Weyand C . Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012; 18(10):1518-24. PMC: 3466346. DOI: 10.1038/nm.2963. View

4.
Zhou N, Li Q, Lin X, Hu N, Liao J, Lin L . BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell Tissue Res. 2016; 366(1):101-11. DOI: 10.1007/s00441-016-2403-0. View

5.
Yu B, Ma J, Li J, Wang D, Wang Z, Wang S . Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat Commun. 2020; 11(1):2549. PMC: 7242393. DOI: 10.1038/s41467-020-16312-7. View